Navigation Links
Osteoporosis drug builds bone in patients with gum disease
Date:10/19/2010

ceived a placebo.

After one year, researchers saw a 29 percent improvement in bone-level measurements on x-rays in the teriparatide group, versus a 3 percent improvement in the placebo group, a 10-fold increase.

"I think one really interesting aspect of this study is that even a short dosing of this drug had benefits that lasted a year," said Laurie McCauley, U-M professor and chair of periodontics and oral medicine, and principal investigator on the study.

McCauley's research lab has spent nearly two decades studying how parathyroid hormone works. Animal models suggest that it works even better in certain bone wound-healing situations, such as those that involve surgery, than in osteoporosis, which is a diminishing of the bone rather than a wound.

"There was speculation that the bone that forms in a wound like a fracture or inflammatory disease condition might be more responsive to being built back than other bone," said McCauley, who noted that this proved true in the experimental group.

McCauley said the next step is for U-M researchers to test whether the treatment could be delivered locally to target site-specific bone healing. Forteo is not FDA approved for uses other than osteoporosis, but another possible application could be to help grow bone around dental implants.


'/>"/>

Contact: Laura Bailey
baileylm@umich.edu
734-647-1848
University of Michigan
Source:Eurekalert

Page: 1 2

Related biology news :

1. Take advantage of reduced pre-registration rates for the IOF World Congress on Osteoporosis
2. Nutrition and bone health session to open the IOF World Congress on Osteoporosis in Bangkok
3. Less than one month to opening of world’s largest global congress on osteoporosis
4. World Congress on Osteoporosis 2010 -- IOFWCO-ECCEO10 to be held in Florence
5. World Congress on Osteoporosis 2010 presents outstanding scientific program
6. World Congress on Osteoporosis 2010 -- IOF WCO -- ECCEO10
7. University of Pittsburgh researchers launching trial of new osteoporosis drug
8. World Congress on Osteoporosis 2010 -- IOF WCO-ECCEO10
9. Announcing IOF Regionals 1st Asia-Pacific osteoporosis meeting
10. Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10
11. Register now online for the World Congress on Osteoporosis 2010 -- IOF WCO-ECCEO10
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 15, 2014 The Defense Logistics Agency ... to detect and prevent counterfeit microcircuits from entering ... agency started performing an in-house microcircuit anti-counterfeit initiative ... authenticity of purchased microcircuits while increasing their reliability ... measures will be conducted at DLA,s Electronics Product ...
(Date:12/17/2014)... , Dec. 16, 2014  Automation is ... this more evident than at international borders. Over ... document scanners have allowed veteran travelers to self ... Passport Control (APC) Kiosks at an increasing number ... globe. According to Maxine ...
(Date:12/11/2014)... WINSTON SALEM, N.C. , Dec. 10, 2014  That ... known for quite a while. Hypertension – the medical term ... disease in the early 1800s, and the inflatable cuff that,s ... That doesn,t, however, mean there,s nothing new about hypertension, ... punctured some long-held beliefs about the condition and the best ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... Fla. (April 19, 2010) A unique cell type ... (olfactory system) known as olfactory ensheathing cells (OECs), possess ... and have become prime candidates for transplantation to repair ... (CNS). Transplanted OECs, known to retain exceptional plasticity and ...
... new, dissolvable nicotine pellet--which is being sold as a ... candies--could lead to accidental nicotine poisoning in children, according ... Public Health (HSPH), the Northern Ohio Poison Control Center, ... the Food and Drug Administration (FDA). The researchers also ...
... out Nature,s purpose behind an astonishing variety of tiny ocean ... ticket-holder in life,s lottery, awaiting conditions that will allow it ... of the hardest-to-see sea species -- tiny microbes, zooplankton, larvae ... all other life on Earth -- is the focus of ...
Cached Biology News:Cell transplants may benefit children with cerebral palsy 2Tobacco company's new, dissolvable nicotine products could lead to accidental poisoning 2Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 2Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 3Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 4Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 5Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 6Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 7Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 8Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 9Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 10
(Date:12/17/2014)... 2014 CASI Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapeutics addressing cancer and ... a primary commercial focus on China ... Type C meeting with the U.S. Food and Drug ... in February 2015.  During this meeting the Company will ...
(Date:12/15/2014)... METTLER TOLEDO is pleased to announce that the ... PVM technology , is now available. The new ... continuously captures high-resolution images under a wide range ... a report pairing the most relevant images to ... compelling blend of high resolution images and trend ...
(Date:12/15/2014)... Dec. 15, 2014  GlassesOff Inc. (OTCBB: GLSO) announced ... as an independent director of the Company,s Board of ... and served as its CEO until its acquisition by ... $240 million transaction. Recognized as the inventor of the ... AeroScout provided Wi-Fi -based RFID solutions focused on improving ...
(Date:12/13/2014)... CHARLOTTE, N.C. (PRWEB) December 13, 2014 ... (UNC Charlotte) spin-out company has changed its name to ... more accurate representation of where we are today,” said ... “We’ve extended our platform’s applications beyond breast cancer diagnostics ... is a reflection of that evolution.” , Founded in ...
Breaking Biology Technology:CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3CanDiag Inc. Expands Product Scope Under a New Name: OncoTab, Inc. 2
... Pharmaceuticals,Inc. (Nasdaq: ANDS ) announced today that it ... Healthcare Conference on Monday, May 19, 2008 at,10:00 a.m. ... Beach Plaza,Hotel in Monte Carlo, Monaco. Steve Worland, Ph.D., ... overview of Anadys and an,update on its two development-stage ...
... Investments,Inc. (AMEX: MGT ), a technology holding ... today reported financial results,for the first quarter ended ... milestones., Tim Paterson-Brown, MGT Chairman and CEO, ... point for our subsidiaries, Medicsight and,Medicexchange. In the ...
... - Adds significant strategic biotech business experience -, ... Corporation,(Nasdaq: VRNM ), a pioneer in the ... today announced the,appointment of John F. Dee to ... Geoffrey Hazlewood, Ph.D., Senior Vice President of,Research, has ...
Cached Biology Technology:Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences 2MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments 2MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments 3MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments 4Verenium Appoints John F. Dee to Board of Directors 2Verenium Appoints John F. Dee to Board of Directors 3Verenium Appoints John F. Dee to Board of Directors 4Verenium Appoints John F. Dee to Board of Directors 5
Request Info...
... ,ISH Protocol Development ,Probe Titer ... and DNA Screenings in Animal ... ,Double Labeling of RNA / ... ,RNA and DNA Localization in ...
Request Info...
IC50: 190 pg/ml · Limit of detection: 60 pg/ml...
Biology Products: